Literature DB >> 22759351

Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor.

Afroditi K Boutou1, Sarah Karrar, Nicholas S Hopkinson, Michael I Polkey.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a disorder characterized by high mortality. Hemoglobin (Hb) concentration has a prognostic impact on COPD patients receiving long-term oxygen treatment, but its value as an independent predictor of survival among stable COPD outpatients has not been fully clarified by previous studies.
OBJECTIVES: To investigate the potential association between anemia and survival in a cohort of stable COPD outpatients.
METHODS: A cohort of stable COPD patients, who had had their first spirometry, blood count and serum chemistry profile done between October 1999 and November 2010 were retrospectively analyzed. Patients with heart failure, renal impairment, malignancy, recent hemorrhage and other causes of anemia were excluded. Variables that were found to be univariately associated with survival entered a multivariate stepwise Cox regression analysis model, to allow independent predictors of survival to be identified.
RESULTS: Of 294 patients (67.9 ± 9.8 years old, 64.6% male) 15.6% were anemic (Hb <13 g/dl). The median survival differed significantly between anemic [68.7 (18.1-91.5) months] and nonanemic [79.8 (57.5-98.4) months, p = 0.035] individuals. Independent predictors of mortality in the total population were anemia [hazard ratio (HR) 1.87, 95% confidence interval (CI) 1.06-3.29], age (HR 1.08, 95% CI 1.04-1.12) and forced expiratory volume in 1 s (FEV(1)) % predicted (HR 0.94, 95% CI 0.92-0.97); the Hb concentration was neither univariately nor multivariately associated with mortality.
CONCLUSION: This is the first study to indicate that anemia (but not the Hb value) is independently associated with survival in stable COPD outpatients. It would be better to treat this as a categorical variable in future scoring systems.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759351     DOI: 10.1159/000338792

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  24 in total

Review 1.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

2.  Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.

Authors:  Nirupama Putcha; Ashraf Fawzy; Gabriel G Paul; Allison A Lambert; Kevin J Psoter; Venkataramana K Sidhaye; John Woo; J Michael Wells; Wassim W Labaki; Claire M Doerschuk; Richard E Kanner; MeiLan K Han; Carlos Martinez; Laura M Paulin; Fernando J Martinez; Robert A Wise; Wanda K O'Neal; R Graham Barr; Nadia N Hansel
Journal:  Ann Am Thorac Soc       Date:  2018-06

3.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

4.  Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumonia.

Authors:  Hong-Joon Shin; Cheol-Kyu Park; Tae-Ok Kim; Hee-Jung Ban; In-Jae Oh; Yu-Il Kim; Yong-Soo Kwon; Young-Chul Kim; Sung-Chul Lim
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 5.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

6.  The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Suzanne M Cloonan; Sharon Mumby; Ian M Adcock; Augustine M K Choi; Kian Fan Chung; Gregory J Quinlan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 7.  Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact.

Authors:  Malay Sarkar; Puja Negi Rajta; Jasmin Khatana
Journal:  Lung India       Date:  2015 Mar-Apr

8.  Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors.

Authors:  Michael H Cho; Brian D Hobbs; Jingzhou Zhang; Dawn L DeMeo; Edwin K Silverman; Barry J Make; R Chad Wade; J Michael Wells
Journal:  BMC Pulm Med       Date:  2021-07-14       Impact factor: 3.320

9.  Polycythemia is Associated with Lower Incidence of Severe COPD Exacerbations in the SPIROMICS Study.

Authors:  Ashraf Fawzy; Han Woo; Aparna Balasubramanian; Igor Barjaktarevic; R Graham Barr; Russell P Bowler; Alejandro P Comellas; Christopher B Cooper; David Couper; Gerard J Criner; Mark T Dransfield; MeiLan K Han; Eric A Hoffman; Richard E Kanner; Jerry A Krishnan; Fernando J Martinez; Meredith McCormack; Robert Paine Iii; Stephen Peters; Robert Wise; Prescott G Woodruff; Nadia N Hansel; Nirupama Putcha
Journal:  Chronic Obstr Pulm Dis       Date:  2021-07-28

10.  A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.

Authors:  Annabel H Nickol; Matthew C Frise; Hung-Yuan Cheng; Anne McGahey; Bethan M McFadyen; Tara Harris-Wright; Nicole K Bart; M Kate Curtis; Shivani Khandwala; David P O'Neill; Karen A Pollard; F Maxine Hardinge; Najib M Rahman; Andrew E Armitage; Keith L Dorrington; Hal Drakesmith; Peter J Ratcliffe; Peter A Robbins
Journal:  BMJ Open       Date:  2015-07-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.